Back to Trades
D'Silva Andrew J.
Chief Business OfficerCIK 0002083717
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 9 filings between 2025–2026, D'Silva Andrew J., Chief Business Officer, has disclosed $447.0K in transactions — all concentrated in OptimizeRx Corp (OPRX). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Oct 2 | OPRX OptimizeRx Corp | D'Silva Andrew J. | Chief Business Officer | Tax withheld | $3.5K |
| Sep 2 | OPRX OptimizeRx Corp | D'Silva Andrew J. | Chief Business Officer | Tax withheld | $11.3K |
| Aug 24 | OPRX OptimizeRx Corp | D'Silva Andrew J. | Chief Business Officer | Grant | $0 |
| Aug 24 | OPRX OptimizeRx Corp | D'Silva Andrew J. | Chief Business Officer | Tax withheld | $9.6K |
| Dec 22 | OPRX OptimizeRx Corp | D'Silva Andrew J. | Chief Business Officer | Tax withheld | $9.5K |
| Dec 15 | OPRX OptimizeRx Corp | D'Silva Andrew J. | Chief Business Officer | Tax withheld | $12.2K |
| Nov 7 | OPRX OptimizeRx Corp | D'Silva Andrew J. | Chief Business Officer | Tax withheld | $22.7K |
| Oct 7 | OPRX OptimizeRx Corp | D'Silva Andrew J. | Chief Business Officer | Other | $0 |
| Oct 7 | OPRX OptimizeRx Corp | D'Silva Andrew J. | Chief Business Officer | Grant | $378.3K |
9 filings